|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 37/10 | |
| A61K 31/19 | |||
| A61K 31/192 | |||
| A61K 31/485 | |||
| A61P 41/00 | |||
| A61K 9/00 | |||
| A61K 9/08 |
| (11) | Number of the document | 3417708 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18183929.1 |
| Date of filing the European patent application | 2010-03-12 | |
| (97) | Date of publication of the European application | 2018-12-26 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-17 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 159585 P | 2009-03-12 | US |
| (72) |
Pavliv, Leo, US
|
| (73) |
Cumberland Pharmaceuticals, Inc.,
2525 West End Avenue, Suite 950, Nashville, TN 37203,
US
|
| (54) | ADMINISTRATION OF INTRAVENOUS IBUPROFEN |
| ADMINISTRATION OF INTRAVENOUS IBUPROFEN |